# DrChrono

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drchrono

- Industry: Software
- Headquarters: Sunnyvale, US
- Website: www.drchrono.com
- Total disclosed funding: $18M
- Latest round: Series A (Apr 6, 2017)
- Investors on record: 8

## About

DrChrono Inc. provides innovative healthcare technology solutions, specializing in electronic health records (EHR) and integrated telehealth services to enhance medical practice operations and patient management.Founded in 2009 in Sunnyvale, US, DrChrono Inc. focuses on developing solutions for healthcare providers. The company, led by CEO Michael Nusimow, has successfully raised USD 12.00 mn through its GROWTH funding round in November 2021, with ORIX Growth Capital as the primary investor. DrChrono has completed a total of 13 funding deals, with its most recent transaction being an acquisition agreement with EverCommerce Inc. Financial terms were not disclosed.DrChrono offers a comprehensive suite of technology-driven solutions tailored specifically for the healthcare industry. Their core product is an electronic health record (EHR) system designed to streamline patient management and enhance clinical workflows. This platform enables healthcare providers to access patient records, schedule appointments, and bill for services, all within a unified interface. Additional offerings include telehealth solutions that facilitate remote patient consultations and a medical billing service aimed at optimizing revenue cycle management. The company primarily serves medical practices, including individual practitioners and group practices, across various geographical markets such as the United States, Canada, and select regions in Europe. These products are designed to address common inefficiencies in healthcare delivery, helping providers improve patient care and operational efficiency.DrChrono generates revenue through a subscription-based model, allowing healthcare providers to access its EHR and related services. Clients typically pay a monthly fee based on the size of their practice and the specific services utilized, which may include individual features such as telehealth and billing solutions. The company’s revenue structure is designed to accommodate a diverse range of practices, from solo practitioners to larger medical groups, each selecting the plans that best fit their operational needs. For instance, a standard subscription may cover essential EHR functionalities, while additional fees could be incurred for advanced features like integrated telehealth services.DrChrono is focused on expanding its health services solutions through its partnership with EverCommerce Inc. The acquisition agreement in November 2021 is expected to enhance DrChrono's offerings and support its growth strategy. Future initiatives may include the launch of new products designed to further streamline healthcare operations, with specific details on these products and release dates to be determined. Additionally, DrChrono aims to expand its presence in new markets, particularly in Europe, where further penetration is anticipated in the coming years.

## Funding rounds

- Series A, Apr 6, 2017, $12M — Runa Capital, FundersClub, Maxfield Capital
- Seed, Dec 12, 2011, $4.9M — Y Combinator, Rock Health
- Seed, Aug 18, 2011, $0.7M — General Catalyst Partners
- Seed, Jul 14, 2011, $0.7M — CRV, General Catalyst Partners, 500 Global

## Investors

- CRV (https://capitalatlas.ai/funds/crv) — Seed
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed
- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Rock Health (https://capitalatlas.ai/funds/rock-health) — Seed
- Runa Capital (https://capitalatlas.ai/funds/runa-capital) — Series A
- FundersClub (https://capitalatlas.ai/funds/fundersclub) — Series A
- Maxfield Capital (https://capitalatlas.ai/funds/maxfield-capital) — Series A